Volume 73, Number 4, July 28, 2009
About this course
- Released: 07/27/2009
- Expires: 07/28/2011
Learning Objectives:
Upon completion of the article by Shimada et al., the participant should be able to:
• List the areas showing less acetylcholinesterase (AChE) activity in the Parkinson disease with dementia group (PDD) versus the Parkinson group (PD)
• State the area showing the greatest reduction in AChE activity in the PDD and Dementia with Lewy Bodies (DLB) groups versus the healthy controls
• State the area of the brain showing the most significant reduction in AChE activity in the de novo early PD, early PD, and advanced PD groups versus healthy controls
Core Competencies:
The article by Shimada et al. covers the following core competency:
• Medical Knowledge
Upon completion of the article by Vemuri et al., the participant should be able to:
• State the best predictor of variability in scores on the Clinical Dementia Rating Scale- Sum of Boxes (CDR-SB)
• State the best predictor of time to Alzheimer disease (AD)
• State the annual change in CDR-SB for patients with AD vs amnestic Mild Cognitive Impairment
Core Competencies:
The article by Vemuri et al. covers the following core competency:
• Medical Knowledge
Author Disclosures: Refer to Information and Author section available in the Tool Bar for each article.
THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES
ACCREDITATION STATEMENT
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed. Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
MISSION STATEMENT/PROGRAM OBJECTIVES
After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.
PARTICIPANTS
This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.
CREDITS
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed.
The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.
DISCLOSURES
Steven Lewis, MD, has received personal compensation in an editorial capacity for the National Board of Medical Examiners and the American College of Physicians; Paul Schulz, MD, has received personal compensation for activities with Pfizer.
COMMERCIAL SUPPORT
This CME program receives no commercial support.
